AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Abivax SA Appoints Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer
Abivax SA has announced the appointments of Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer. This leadership change comes as the company prepares for the potential commercialization of its lead product, obefazimod. The transition is expected to strengthen their capabilities in regulatory and launch execution.
Company Information
Company
Abivax
Location
Rue De La Baume
Paris, Ile-de-France, France
About
Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.
Fundz sees it the moment Abivax changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ParisBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharma